Sage Therapeutics | 10-Q: Quarterly report
Apr 25 19:20
Sage Therapeutics | 8-K: Sage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business Progress
Apr 25 18:50
Sage Therapeutics | ARS: Annual Report to Security Holders
Apr 25 04:19
Sage Therapeutics | DEFA14A: Others
Apr 25 04:16
Sage Therapeutics | DEF 14A: Definitive information statements
Apr 25 04:10
Sage Therapeutics | 8-K: Current report
Apr 19 20:33
Sage Therapeutics | 8-K: Current report
Apr 17 18:38
Sage Therapeutics | SC TO-I/A: Third party tender offer statement (Amendment)
Mar 28 04:15
Sage Therapeutics | 8-K: Current report
Mar 26 20:39
Sage Therapeutics | SC TO-I/A: Third party tender offer statement (Amendment)
Feb 22 05:44
Sage Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Greene Barry E
Feb 16 06:08
Sage Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cook Anne Marie
Feb 16 06:08
Sage Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gault Laura
Feb 16 06:08
Sage Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer IGUCHI KIMI
Feb 16 06:03
Sage Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Benecchi Christopher
Feb 16 06:03
Sage Therapeutics | SC TO-I/A: Third party tender offer statement (Amendment)
Feb 15 06:56
Sage Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Feb 14 20:51
Sage Therapeutics | 10-K: Annual report
Feb 14 20:22
Sage Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-RTW Investments, LP(8.7%),Roderick Wong, M.D.(8.7%)
Feb 14 20:12
Sage Therapeutics | 8-K: Sage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business Progress
Feb 14 19:46
No Data
No Data